Peroxisome proliferator-activated receptors-α (PPARs-α) are
nuclear receptors with anti-inflammatory properties.
Zinc gluconate is efficient in the treatment of several inflammatory
dermatoses. The aim of our work was to determine whether the modulation of
PPAR-α expression and activity could be one of the mechanisms of action of
zinc gluconate anti-inflammatory activity in inflammatory
dermatoses. Thus, we used ex vivo skin explants incubated with
lipopolysaccharide (LPS), a pro-inflammatory molecule, with or without
zinc gluconate. We evaluated
PPAR-α
protein expression using immunohistochemistry,
PPAR-α
DNA-binding activity using an ELISA-like technique, and
PPAR-α
mRNA levels using quantitative PCR. On the one hand, we found that
PPAR-α epidermal
protein expression was stimulated by LPS and that LPS suppressed
PPAR-α
mRNA expression, without modifying its function. On the other hand, in inflammatory LPS-stimulated explants,
zinc gluconate significantly upregulated
PPAR-α function and
mRNA expression level, without changing its epidermal
protein expression. These results suggest that
zinc gluconate may be a
PPAR-α agonist, which might play a role in the anti-inflammatory activity of this molecule.